Introduction to Ertasave 1gm Injection
Ertasave 1gm injection is an antibiotic drug in the carbapenems category, containing the active ingredient Ertapenem. It is used to treat various bacterial infections caused by susceptible organisms. This injection also treats skin, lung, urine, and gynecological infections. Mostly, it can be used during the prevention of surgical site infections.
Ertasave 1gm injection is contraindicated in individuals with known hypersensitivity or allergic reactions to other beta-lactam antibiotics, such as penicillins or cephalosporins. This drug should be used cautiously or avoided. Also, it can reduce the serum concentrations of valproic acid, a medication used to treat seizures and certain mental health conditions. It can lead to decreased effectiveness of valproic acid. If you take valproic acid, your healthcare provider may need to adjust the dose or consider alternative treatments. This medicine use has been associated with developing Clostridium difficile-associated diarrhea (CDAD) and colitis, severe antibiotic-associated diarrhea.
If you experience severe or bloody stools while taking this injection, it is important to inform your doctor. Before taking Ertasave 1gm injection, discussing your medical history with your doctor is necessary. Inform them if you have allergic conditions, kidney disease, or if you are on a salt-controlled diet. These factors may require special consideration or monitoring during treatment. If you suspect pregnancy or plan to have a baby, inform your doctor about all the medications you have been taking recently, including herbal and supplements.
Therapeutic Effects of Ertasave 1gm Injection
Ertasave 1gm injection works by inhibiting the growth of bacteria and preventing them from multiplying. It does this by interfering with the bacterial cell wall synthesis, which is essential for survival.
Interaction of Ertasave 1gm Injection with other drugs
Inform your physician about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications like valproic acid may interact with Ertasave 1gm injection and reduce effectiveness by causing undesirable side effects.
More Information about Ertasave 1gm Injection
- Store Ertasave 1gm injection in a refrigerator (2 – 8°C).
- Do not freeze.
How to consume Ertasave 1gm Injection
Ertasave 1gm injection will be administered to you by a healthcare professional in a hospital setting. It is usually administered as an intravenous injection into a vein. Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.
Safety Advices for Ertasave 1gm Injection
Pregnancy
If you are pregnant, suspecting, or planning for the pregnancy, report to your doctor before starting the treatment with Ertasave 1gm Injection. Consult your doctor for more advice.
Breast Feeding
Taking Ertasave 1gm injection during breastfeeding is unsafe because it tends to get excreted in human milk.
Lungs
Ertasave 1gm injection is safe when administered in patients with lung disease. No dose adjustments are necessary.
Liver
Ertasave 1gm injection should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary. Inform your doctor if you have liver issues before initiating the therapy.
Alcohol
Consuming alcohol may affect the effectiveness of Ertasave 1gm injection. It is highly advised to stop consuming alcohol if you take this medicine.
Driving
Driving vehicles or operating heavy machinery is unsafe after taking Ertasave 1gm injection. It may cause dizziness and impair concentration.
Side Effects of Ertasave 1gm Injection
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
- Fainting
- Muscle cramp
- Bowel incontinence
- Difficulty in swallowing
Common
- Infusion site reaction
- Rash
- Dizziness
- Insomnia (difficulty in sleeping)
- Breathlessness
- Headache
- Vomiting
- Nausea
- Diarrhea
Reviews
There are no reviews yet.